Doebele Robert

See RemarksRain Oncology Inc. (RAIN) · full profile →Form 4 · filed Jan 26, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
13
1 non-derivative · 12 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2024Tender(U)477K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 26, 2024Disposed to issuer(D)11K0
Jan 26, 2024Disposed to issuer(D)91K0
Jan 26, 2024Disposed to issuer(D)12K0
Jan 26, 2024Disposed to issuer(D)5K0
Jan 26, 2024Disposed to issuer(D)14K0
Jan 26, 2024Disposed to issuer(D)112K0
Jan 26, 2024Disposed to issuer(D)9K0
Jan 26, 2024Disposed to issuer(D)99K0
Jan 26, 2024Disposed to issuer(D)50K0
Jan 26, 2024Disposed to issuer(D)9K0
Jan 26, 2024Disposed to issuer(D)2K0
Jan 26, 2024Disposed to issuer(D)60K0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001999371-24-000958) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about RAIN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001999371-24-000958"
Ask your agent
Use Arkolith to summarize insider buying and selling at Rain Oncology Inc.
over the last 90 days and cite the filings.